What is HC Wainwright’s Estimate for Senseonics Q2 Earnings?

Senseonics Holdings, Inc. (NYSE:SENS) – Stock analysts at HC Wainwright issued their Q2 2025 earnings estimates for Senseonics in a report issued on Monday, June 2nd. HC Wainwright analyst S. Lee anticipates that the company will post earnings per share of ($0.02) for the quarter. HC Wainwright currently has a “Buy” rating and a $1.10 target price on the stock. The consensus estimate for Senseonics’ current full-year earnings is ($0.14) per share. HC Wainwright also issued estimates for Senseonics’ Q3 2025 earnings at ($0.02) EPS, Q3 2026 earnings at ($0.01) EPS, Q4 2026 earnings at ($0.01) EPS, FY2026 earnings at ($0.06) EPS, FY2028 earnings at ($0.01) EPS and FY2029 earnings at $0.01 EPS.

Senseonics (NYSE:SENS) last released its quarterly earnings results on Monday, March 3rd. The company reported ($0.12) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.09). Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. During the same period in the previous year, the business earned ($0.07) earnings per share.

A number of other equities analysts also recently weighed in on SENS. Wall Street Zen upgraded Senseonics to a “sell” rating in a research note on Monday, May 12th. Mizuho began coverage on Senseonics in a research note on Thursday, April 10th. They issued an “outperform” rating and a $2.00 target price on the stock.

Senseonics Trading Down 0.0%

NYSE SENS opened at $0.53 on Tuesday. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. The firm has a market capitalization of $346.54 million, a P/E ratio of -4.07 and a beta of 1.05. Senseonics has a 12 month low of $0.25 and a 12 month high of $1.40. The business has a fifty day simple moving average of $0.61 and a 200 day simple moving average of $0.65.

Institutional Trading of Senseonics

Large investors have recently added to or reduced their stakes in the stock. Raymond James Financial Inc. purchased a new stake in shares of Senseonics during the 4th quarter worth approximately $26,000. IFP Advisors Inc grew its stake in shares of Senseonics by 120.9% during the 1st quarter. IFP Advisors Inc now owns 47,500 shares of the company’s stock worth $31,000 after acquiring an additional 26,000 shares during the period. CTC Alternative Strategies Ltd. bought a new stake in Senseonics in the 1st quarter valued at about $31,000. HighTower Advisors LLC bought a new stake in Senseonics in the 4th quarter valued at about $32,000. Finally, Two Sigma Investments LP bought a new stake in Senseonics in the 4th quarter valued at about $36,000. Hedge funds and other institutional investors own 12.36% of the company’s stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.